Navigation Links
DNA Medicine Institute Receives Qualifying Therapeutic Discovery Grant
Date:11/3/2010

CAMBRIDGE, Mass., Nov. 3, 2010 /PRNewswire/ -- The DNA Medicine Institute, a biomedical research organization whose mission is to advance patient care, alleviate human suffering, and treat disease through innovation, has received a $222,999 grant from the U.S. government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its Universal Blood Sensor. The QTDP grant program, established as a result of the Patient Protection and Affordable Care Act of 2010, targeted projects that show potential to result in new therapies to treat areas of unmet medical need or prevent, detect or treat chronic or acute diseases and conditions, reduce long-term health care costs in the United States, or significantly advance the goal of curing cancer within the next 30 years. Allocation of the credit also took into consideration which projects show the greatest potential to create and sustain high-quality, high-paying U.S. jobs and to advance U.S. competitiveness in life, biological and medical sciences.

DMI's Universal Blood Sensor offers a full system's check of a person anywhere, anytime, and with a single drop of blood—all without the use of a hospital-sized testing center, a phlebotomist, and skilled medical practitioners. The sensor allows for all disease states from all organs to be analyzed, whether this involves the heart, blood, lungs, brain, kidneys, cancer, or infection. Real-time decision analysis allows the user to proceed with optimal management in the event of an abnormal state.

Eugene Chan, M.D., President and Chief Scientific Officer of the DNA Medicine Institute, commented:  "This funding will allow us to speed the development of innovations for making vital diagnostic information readily available to all patients regardless of their setting, need, or economic condition."

About DNA Medicine Institute

DMI utilizes an interdisciplinary, multi-faceted approach to innovation that draws upon diverse and disparate fields including medicine, nanotechnology, genomics, biophysics, biochemistry, molecular biology, and advanced engineering.  Its core beliefs are that successful, innovative commercial products can make a long-lasting impact on patient care. It currently does research on intuitive medical devices, smartly designed drugs, and powerful research instrumentation.  For more information, visit:  www.dnamedinstitute.com.


'/>"/>
SOURCE DNA Medicine Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited
2. CTIA-The Wireless Association® to Host First Wireless Health Pavilion at MEDICA 2010 World Forum for Medicine
3. Reproductive Medicine Associates of NJ Receive Top National Award for Ground-Breaking IVF Research
4. Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
5. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
6. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
7. China Medicine to Announce Third Quarter 2010 Financial Results on November 10, 2010
8. INVOcell Study Results to be Reported at the Annual Meeting of The American Society of Reproductive Medicine
9. Emergency Physicians Urge Americans to Take The American Medicine Chest Challenge November 13th
10. C PORT Solutions Launches MEDI PORT to Bring Powerful New Telemedicine Solutions to the Hospital Bedside
11. Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology:
(Date:9/21/2017)... ... September 21, 2017 , ... ... with Infinity Behavioral Health Services for professionals in the addiction treatment industry entitled: ... Audit . , Insurance companies and state and federal governments are increasingly ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is to create an ... to the community. For over 37 years, they have operated with their mission at ... in San Diego. They were chosen as the Best San Diego plumber in ...
(Date:9/21/2017)... ... 21, 2017 , ... Preora Diagnostics Inc. , a ... has received two prestigious recognitions that acknowledge the promise of its PWS Nanoctyology ... has been named a Top 100 Finalist for the 16th annual Chicago Innovation ...
(Date:9/21/2017)... TX (PRWEB) , ... September 21, 2017 , ... ... senior housing operators, announces the acquisition of Isle at Kingwood Assisted Living and ... Kingwood is an established retirement community with 55 assisted living apartments, 43 memory ...
(Date:9/20/2017)... ... September 20, 2017 , ... FirstAlign ( http://www.firstalign.com ... the latest Artificial Intelligence (AI) thinking, announced today the launch of its revamped ... to essential information that offers a more comprehensive understanding of the organization’s business ...
Breaking Medicine News(10 mins):